This week, MIT announced a new technique for treating triple-negative breast cancer. Researchers found that by using "stealth" nanoparticles and RNA strands, they can contain and attack cells that were once resistant to therapies. Researchers are hoping to use this method to treat other types of cancer in the future as well.
Their "one-two punch" strategy uses the "stealth" nanoparticles carrying the cancer drug doxorubicin, as well as short strands of RNA that can shut off one of the genes that cancer cells use to escape the drug, according to an announcement. An outer layer protects the particle from degradation in the bloodstream, which had been a problem in developing such a strategy previously.
Drug delivery technology innovations are infiltrating the market at the
speed of light. The Innovation Theater at IIR's 18th Annual Drug Delivery Partnerships showcases the newest and most cutting-edge technologies. To learn more, download our agenda
As a reader of this blog you'll receive $100 off of the standard rate when you use priority code XP1978BLOG to register. We hope to see you January 27-29 in Boca Raton!